Complete Remission in Two Cases of Adult T-Cell Leukemia/Lymphoma Treated With Hyper-CVAD: A Case Report and Review of the Literature
- 1 December 2010
- journal article
- case report
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 10 (6), 480-483
- https://doi.org/10.3816/clml.2010.n.084
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Treatment of adult T‐cell leukemia/lymphoma: past, present, and futureEuropean Journal of Haematology, 2007
- HTLV in the Americas: challenges and perspectivesRevista Panamericana de Salud Pública, 2006
- The human T‐cell leukemia virus type 1 (HTLV‐1): New insights into the clinical aspects and molecular pathogenesis of adult t‐cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV‐associated myelopathy (TSP/HAM)Microscopy Research and Technique, 2005
- Global epidemiology of HTLV-I infection and associated diseasesOncogene, 2005
- Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)Retrovirology, 2005
- Pathogenesis and Treatment of Human T-Cell Leukemia Virus InfectionImmunologic Research, 2005
- Immunological risks of adult T-cell leukemia at primary HTLV-I infectionTrends in Microbiology, 2004
- Denileukin Diftitox and Hyper-CVAD in the Treatment Human T-Cell Lymphotropic Virus 1–Associated Adult T-Cell Leukemia/LymphomaClinical Lymphoma, 2003
- Adult T-Cell Leukemia/lymphoma: A Rare Case in the USA and Review of the LiteratureLeukemia & Lymphoma, 2002
- Molecular biology and pathogenesis of the human T‐cell leukaemia/lymphotropic virus Type‐1 (HTLV‐1)International Journal of Experimental Pathology, 2001